Lupin Limited (LUPIN.BO)
Lupin Limited, operates as a pharmaceutical company in India, the United States, and internationally.
2,419.10-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-0.9%
The outlook
Lupin Limited currently reads as bullish based on buy — 1.9 avg of 38 analysts, above its 50- & 200-day averages, 92% of the way from its 52-week low to high, avg target -5% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 38 analysts
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Price targetAvg target -5% vs current price
Analyst price target
~12-month · 38 analysts2,306.18average target-4.7% vs now
Now 2,419.10
Low 1,903.00High 2,600.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.11T
52-wk high
2,475.00
52-wk low
1,774.00
50-day avg
2,122.03
200-day avg
2,010.88
Trailing P/E
25.6